GLP-1 Eligibility Checker
Do you qualify for Ozempic, Wegovy, Mounjaro, or Zepbound? Check FDA criteria instantly.
FDA Criteria for GLP-1 Weight Loss Medications
The FDA has approved GLP-1 receptor agonists for chronic weight management using two primary pathways: BMI of 30 or higher (classified as obesity), or BMI of 27 or higher with at least one weight-related comorbidity. These are the same criteria used by the American Obesity Association and most insurance companies for coverage decisions.
BMI Requirements for Wegovy, Zepbound, Ozempic, Mounjaro
Wegovy (semaglutide 2.4mg): obesity/weight management, BMI 30 or higher, or BMI 27 plus one condition. Zepbound (tirzepatide): same criteria as Wegovy. Ozempic (semaglutide 1mg): Type 2 Diabetes, any BMI with T2D diagnosis. Mounjaro (tirzepatide): Type 2 Diabetes, any BMI with T2D diagnosis.
Medical Conditions That May Help You Qualify at BMI 27+
If your BMI is between 27 and 30, qualifying comorbidities include hypertension, type 2 diabetes, hyperlipidemia, obstructive sleep apnea, cardiovascular disease, and non-alcoholic steatohepatitis. This recognizes that metabolic health risks are not perfectly correlated with BMI — some individuals at BMI 27-30 have significant health burdens that benefit from GLP-1 therapy.
What to Expect at Your GLP-1 Consultation
A telehealth GLP-1 consultation typically takes 15-30 minutes. The provider reviews your medical history, current medications, BMI, and contraindications. Lab work may be ordered but is often not required initially. Many telehealth providers can have your prescription filled and shipped within a few days of consultation.
Frequently Asked Questions
Can I get GLP-1 if my BMI is under 27?
Generally not for weight loss through conventional channels. Some providers may prescribe off-label for specific metabolic indications at lower BMIs, but this is not standard practice.
Does my BMI have to be exactly 30?
Providers calculate BMI from your actual height and weight at evaluation. Slight measurement differences can affect the number, but providers evaluate the full clinical picture.
I have Type 2 diabetes but BMI is 24. Can I get GLP-1?
Yes. Ozempic and Mounjaro are FDA-approved for Type 2 diabetes management regardless of BMI. These medications improve blood sugar control and provide cardiovascular benefits.
What if I was denied by one provider?
Different providers have different prescribing practices. If you believe you meet criteria and were denied, seeking a second opinion is reasonable.
Do I need to prove my weight-related condition?
Typically yes — providers may request recent lab results or medication list to document conditions like hypertension or high cholesterol, which also helps them prescribe safely.